Your browser doesn't support javascript.
loading
Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer.
Dohmen, Jonas; Semaan, Alexander; Kobilay, Makbule; Zaleski, Martin; Branchi, Vittorio; Schlierf, Anja; Hettwer, Karina; Uhlig, Steffen; Hartmann, Gunther; Kalff, Jörg C; Matthaei, Hanno; Lingohr, Philipp; Holdenrieder, Stefan.
Afiliação
  • Dohmen J; Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital, 53127 Bonn, Germany.
  • Semaan A; Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital, 53127 Bonn, Germany.
  • Kobilay M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, 53127 Bonn, Germany.
  • Zaleski M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, 53127 Bonn, Germany.
  • Branchi V; Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital, 53127 Bonn, Germany.
  • Schlierf A; QuoData GmbH-Quality & Statistics, 01309 Dresden, Germany.
  • Hettwer K; CEBIO GmbH-Center for Evaluation of Biomarkers, 81679 Munich, Germany.
  • Uhlig S; QuoData GmbH-Quality & Statistics, 01309 Dresden, Germany.
  • Hartmann G; CEBIO GmbH-Center for Evaluation of Biomarkers, 81679 Munich, Germany.
  • Kalff JC; QuoData GmbH-Quality & Statistics, 01309 Dresden, Germany.
  • Matthaei H; CEBIO GmbH-Center for Evaluation of Biomarkers, 81679 Munich, Germany.
  • Lingohr P; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, 53127 Bonn, Germany.
  • Holdenrieder S; Center for Integrated Oncology (CIO) Cologne/Bonn, 53127 Bonn, Germany.
Diagnostics (Basel) ; 12(6)2022 Jun 08.
Article em En | MEDLINE | ID: mdl-35741223
ABSTRACT

Background:

Despite the significance of colonoscopy for early diagnosis of colorectal adenocarcinoma (CRC), population-wide screening remains challenging, mainly because of low acceptance rates. Herein, exosomal (exo-miR) and free circulating microRNA (c-miR) may be used as liquid biopsies in CRC to identify individuals at risk. Direct comparison of both compartments has shown inconclusive results, which is why we directly compared a panel of 10 microRNAs in this entity.

Methods:

Exo-miR and c-miR levels were measured using real-time quantitative PCR after isolation from serum specimens in a cohort of 69 patients. Furthermore, results were compared to established tumor markers CEA and CA 19-9.

Results:

Direct comparison of exo- and c-miR biopsy results showed significantly higher microRNA levels in the exosomal compartment (p < 0.001). Exo-Let7, exo-miR-16 and exo-miR-23 significantly differed between CRC and healthy controls (all p < 0.05), while no c-miR showed this potential. Sensitivity and specificity can be further enhanced using combinations of multiple exosomal miRNAs.

Conclusions:

Exosomal microRNA should be considered as a promising biomarker in CRC for future studies. Nonetheless, results may show interference with common comorbidities, which must be taken into account in future studies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2022 Tipo de documento: Article